celltrion vegzelma permission canada

Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...

Paris Baguette opened its 600th overseas store in Toronto, Ontario, as the leading South Korean bakery brand is rapidly expanding its global busines...

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Solus Advanced Materials, a South Korean copper foil supplier, said on Friday that its overseas subsidiary Volta Energy Solutions Canada signed an i...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

T'way Air Co. announced on Thursday that it will gradually introduce five new Airbus A330-900 Neo aircraft starting next year.T’way recently s...

KT Corp. unveiled on Monday the Canadian edition of Genie TV's AI Travel View, which was created using generative artificial intelligence technology...

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...

South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...

South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...

South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed...

South Korea's SK Telecom Co. announced on Wednesday that it launched the T In-flight wi-fi service.This service will initially be available on six a...

South Korea's SK Telecom Co. announced on Monday that it signed a distribution agreement with Canadian pet medical equipment company Nuon & Nikk...

South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...

South Korea's Air Premia Inc. announced on Thursday that it partnered with Alaska Airlines, the fifth-largest US carrier, through an interline agr...

Danggeun Market Inc., South Korea’s largest online flea market service provider, is expanding its online used-goods marketplace app Karrot acr...

South Korea's Shinhan Card Co. announced on Wednesday that it signed a strategic business agreement with the provincial government of Alberta, C...

South Korea's Hanwha Ocean Co. announced on Friday that it partnered with three Canadian companies at Canada’s largest defense exhibition, CAN...

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...

Japan’s Honda Motor Co. and South Korea’s POSCO Future M Co. agreed to build a battery materials plant in Canada where the automaker wil...

South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...

POSCO N.EX.T Hub, the venture platform of POSCO Holdings Inc., announced on Thursday that it signed a memorandum of understanding (MOU) with the K...